Weekly Global Logistics & Supply Chain Review | July 24, 2026

The article explains that life sciences companies must expand supply chain visibility beyond their direct suppliers to include transportation routes, ports, airports, customs gateways, carriers, and logistics hubs as geopolitical instability increasingly disrupts global trade. Events such as conflicts in Eastern Europe, Red Sea shipping attacks, and instability in the Middle East have demonstrated how a single disruption can ripple across global logistics networks, threatening clinical trials, manufacturing operations, and patient access to temperature-sensitive medicines. The author argues that proactive geopolitical supply chain mapping, combined with contingency planning, diversified logistics networks, predictive technology, and cross-functional collaboration, enables organizations to identify hidden vulnerabilities before disruptions occur and build the resilience needed to maintain business continuity.

Read the full article